Histological examination of supraclavicular lymph node tissue obtained at biopsy from a 63-year-old man disclosed metastaticsmall-cellcarcinoma. On admissionand for four days subsequently, total lactate dehydrogenase (LD; EC 1.1.1.27) activityin serum was 6.5 times normal; studiesof LD isoenzyme showedpersistentlyincreased LD-1 , with LD-1 >LD-2. lsoenzyme electrophoresis of tissue homogenates prepared from the patient's tumor also showed the LD-1 >LD-2 pattern. lsoenzyme studiesfor supraclavicularlymph node tissue from five control subjects showed contrasting isoenzyme patterns as compared with the patients in whom LD-2, LD-3, and LD-4 predominated.Because these abnormalities were persistent, they differ from the temporal sequence for LD usually seen in myocardial infarction. This emphasizes the importance of repetitivesamplingfor clinical interpretation of data on this enzyme.
the area of the left supraclavicular lymph nodes. Soon after hospital admission, histological examination disclosed metastatic small-cell carcinoma in a scalenelymph nodebiopsy. His past medical history included60 pack-years of cigarette smoking and ethanol abuse, but the patient had no history or clinical signs of heart disease. At admission his total creatine kinase (EC 2.7. 
Materials and Methods
Patient and confrol samples. Serum and cancerous left supraclavicular lymph node tissue were obtained from the patient and evaluated for U) isoenzymes. For use as controls, we obtained ijoncancerous left supraclavicular lymph node specimens from five subjects, three at autopsy and two at surgery. The patient's serum used for the U) isoenzyme studies was separated from cellular material within an hour of collection and stored no longer than 12 h at room temperature. Supraclavicular lymph node specimens, obtained from the patient and five controls, were immersed in a minimum volume ofisotomc saline (NaC1, 150 mmol/L) and stored for not more than 24 h at 4 #{176}C.
Tissue preparation. To prepare tissue extracts for the patient and controls, we made a cross-sectional incision approximately 5 mm from the tip of each supraclavicular lymph node. To each 5-mm lymph node tip, we added three drops of freshly prepared isotonic saline. The tissues were
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Enzyme and isoenzyme analysis. We measured total U) activity kunetically at 30 #{176}C by monitoring, at 340 urn, the reduction of NAD during the LD-CatalyZed lactate-topyruvate reaction (Worthington Statzyme U) (L-P) kit; Cooper Biomedical, Freehold, NJ 07728). We previously had determined a normal reference interval of 50-140 UIL for total U) activity in serum, using the reagents and conditions stated above. U) isoenzymes, separated by electrophoresis on agarose gel, were detected by use of an U) stsining kit containing NAD, Nitro Blue tetrazolium chloride, methoxyphenazune methosulfate, and lithium iAactate (all from Coming Medical, Medfield, MA 02052). The relative activity of each isoenzyme on the gel film was determined by densitometry at 600 urn. Our laboratory's normal reference intervals for serum U) isoenzymes are: 15-27% for LD-1; 28-38% for LD-2; 18-26% for LD-3; 7-15% for LD-4; and 7-17% for LI)-Results Table 1 shows the patient's data for total U) activity, percent LD-1, and LD-1JLD-2 ratio in serum as measured on each of the four days after hospital admission. For total U) in serum during this period, we observed activities that consistently were 6.5 times the upper limit of the normal range. Concurrent serum U) isoenzyme assay during this same period showed persistently increased U)-1, as com--with normal. For all serum specimens we obtained during this four-day period, the LD.-1/LD-2 ratio was greater than unity.
On the fourth day ofhospitalization a left supraclavicular lymph node was resected from the patient, and blood was obtained concurrently. The U) isoenzyme patterns, and densitometric scans we obtained after electrophoresis of the U) isoenzyme data for supraclavicular lymph node tissue from the patient and control subjects are shown in Table 2 . For all five control-subject tissues, the isoenzyme propertions are strikingly similar, the composite activities for LI)-2, LD-3, and LD-4 in these normal tissues accounting for 79% ± 2% (mean ± SD) of total U) activity. For our patient's tissue, however, U) fractionation revealed markedly different proportions for these isoenzymes. Their corn_te activities in the cancerous tissue accounted for only 51% of the total, nearly 30% (or 15 SD) less than in the controls. Data for U)-1 in tissue were also disparate between the controls and our patient.
As shown in Table 2 , LB-i represented only 5-10% oftotal U) activity in control tissue specimens, but was the predominant isoenzyme in the patient's tissue, accounting for 34% of total U) activity. Using data presented in Table 2 , we Calculated the LI)-1/LD-2 ratio for the tissue samples. For the control group samples, this ratio averaged 0.47, substantially less than the ratio of 1.42 for the patient's tissue.
Discussion
We describe a patient with email-cell carcinoma and consistently increased serum U) activity that, upon fractionation, showedpersistently increased LB-i and LB-i >LD-2 in the absence of heart disease, infarction of the renal cortex, or specimen hemolysis. Isoenzyme electrophoreals of tumor tissue homogenates from the patient also showed increased LB-i and LB-i >LD-2. Results of similar isoenzyme studies ofnoncancerous lymph node tissue from a group of control subjects, however, were markedly dissimilar, with LD-2, LD-3, and LD-4 predominating. U) isoenzymes in tissue from human breast tumor (2), adenocarcinoma ofthe colon (3) ,and other tumor types (4, 5) reportedly show U) fractionation patterns in which LD-4 and U)-5 predominate. A prevalence of LD-4 and U)-5 in tumor tissue is not ubiquitous, however. In fact, some cancers typically show a predominance of LB-i as well as the LB-i >LD-2 pattern, as was seen in our patient. Such cancers include adenocarcunoma of the ovary (6),bronchial cancer (7), various stages of malignant hematological disease (8) , seminoma (9) , and selected germ cell tumors (10) .
According to a report by Tanaka et al. (4) , U) fractionation studies with homogenates from small-cell carcinoma tissue typically show isoenzyme patterns in which LD-3 predominates. The patient we describe here, however, having histo-logically verified small-cell carcinoma, showedincreased LB-i activity and the LB-i >U)-2 pattern in serum and tumor tissue, an observation we could not find previously documented. In many patients having "uncomplicated" myocardial infarction, the activity ofLD-i exceeds that ofU)-2 within 5
to 15 h after acute onset of symptoms, with peak total LB activity occurring 48 h after infarction (11) . The patient presented here, having occult disease with no evidence of rnyocardial infarction, showed persistently increased total U) activity, increased LB-i, and the LB-i >U)-2 pattern throughout the four-day period studied. This difference from the temporal sequence characteristic of acute myocardial infarction emphasizes the importance of appropriate repetitive sampling for clinical interpretation of data for U) and its isoenzyrnes.
